Harold E. Windschitl

Author

Also Known As

Goldberg, Richard, H E Windschitl, H Windschitl, H. E. Windschitl, H. Windschitl, H.E. Windschitl, Harold E. Windschitl, Harold Windschitl, Sargent, Daniel J.

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic CentraCare Health System Duluth Clinic Mayo Clinic in Arizona WinnMed

About

Harold E. Windschitl is an author at Mayo Clinic specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1K
2	Health Sciences	7	7	567
3	Clinical Nutrition	1	1	353
4	Gastroenterology	1	1	32
5	Immunology	1	1	29

Harold E. Windschitl

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study Aminah Jatoi, Harold E. Windschitl, Charles L. Loprinzi, Journal of Clinical Oncology Weight ManagementPharmacotherapyCancer-associated AnorexiaObesityFunctional Assessment	2002	353
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. Henry C. Pitot, Donald B. Wender, Matthew J. O’Connell, Journal of Clinical Oncology	1997	257
Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer Amy J. French, Daniel J. Sargent, Lawrence J. Burgart, Clinical Cancer Research	2008	252
Lack of Effect of Coumarin in Women with Lymphedema after Treatment for Breast Cancer Charles L. Loprinzi, John W. Kugler, Jeff A. Sloan, New England Journal of Medicine	1999	178
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer. James N. Ingle, James E. Krook, S J Green, Journal of Clinical Oncology Surgical OncologyMetastatic Breast CancerBreast OncologyMedicineCancer Management	1986	174
Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. Charles L. Loprinzi, Samir Abu-Ghazaleh, Jeff A. Sloan, Journal of Clinical Oncology	1997	168
Prognostic Value of Proliferation, Apoptosis, Defective DNA Mismatch Repair, and p53 Overexpression in Patients With Resected Dukes' B2 or C Colon Cancer Megan M Garrity, Lawrence J. Burgart, Michelle R. Mahoney, Journal of Clinical Oncology	2004	126
Gemcitabine, 5‐fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma Steven R. Alberts, Hani Alkhatib, Michelle R. Mahoney, Cancer	2004	116
Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status Rafaela L. Rego, Nathan R. Foster, Thomas C. Smyrk, British Journal of Cancer	2009	94
Prognostic Impact of Bim, Puma, and Noxa Expression in Human Colon Carcinomas Frank A. Sinicrope, Rafaela L. Rego, Kenji Okumura, Clinical Cancer Research	2008	86

Page 1